Blood Pressure and Dapagliflozin in Heart Failure With Mildly Reduced or Preserved Ejection Fraction: DELIVER.

MLA

Selvaraj, Senthil, et al. “Blood Pressure and Dapagliflozin in Heart Failure With Mildly Reduced or Preserved Ejection Fraction: DELIVER.” JACC. Heart Failure, vol. 11, no. 1, Jan. 2023, pp. 76–89. EBSCOhost, https://doi.org/10.1016/j.jchf.2022.09.002.

APA

Selvaraj, S., Vaduganathan, M., Claggett, B. L., Miao, Z. M., Fang, J. C., Vardeny, O., Desai, A. S., Shah, S. J., Lam, C. S. P., Martinez, F. A., Inzucchi, S. E., de Boer, R. A., Petersson, M., Langkilde, A. M., McMurray, J. J. V., & Solomon, S. D. (2023). Blood Pressure and Dapagliflozin in Heart Failure With Mildly Reduced or Preserved Ejection Fraction: DELIVER. JACC. Heart Failure, 11(1), 76–89. https://doi.org/10.1016/j.jchf.2022.09.002

Chicago

Selvaraj, Senthil, Muthiah Vaduganathan, Brian L Claggett, Zi Michael Miao, James C Fang, Orly Vardeny, Akshay S Desai, et al. 2023. “Blood Pressure and Dapagliflozin in Heart Failure With Mildly Reduced or Preserved Ejection Fraction: DELIVER.” JACC. Heart Failure 11 (1): 76–89. doi:10.1016/j.jchf.2022.09.002.